Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-076892
Filing Date
2025-05-23
Accepted
2025-05-23 16:01:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 14589
2 EX-99.7 ck0000000000-ex99_7.pdf EX-99.7 13869
  Complete submission text file 0000950170-25-076892.txt   35498
Mailing Address 730 FIFTH AVENUE NEW YORK NY 10019
Business Address 730 FIFTH AVENUE NEW YORK NY 10019 2122476400
ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by) CIK: 0001508226 (see all company filings)

EIN.: 133970710 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-456-4393
ACELYRIN, Inc. (Subject) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-94068 | Film No.: 25981971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)